Previous data showed that intratumoral thymidine from necrotic cells inhibited GCLC activity (56) and that GCLC expression was upregulated in IDH1-mutated compared to IDH1 wild-type glioma (57). This evidence concerns the gene IDH1 and central nervous system cancer.